drugset / Trial / NCT01491061
Ranolazine Loading to Prevent PCI-induced Myocardial Injury
RandomizedParallel-groupTriple-blindTreatment
Summary
It has previously been shown that pretreatment with ranolazine 1,000 mg twice daily for 7 days can significantly reduce procedural myocardial injury in elective percutaneous coronary intervention (PCI). The investigators tested the hypothesis that twice overnight high-dose ranolazine loading before PCI can reduce the peri-procedural myocardial ischemic damage similarly to long-term pre-treatment with standard doses.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranolazine | Small molecule | 1000 mg | Oral |